Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,951 public trials 2,018 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, Not Recruiting

Nanochip Technology in Monitoring Treatment Response and Detecting Relapse in Participants With Diffuse Large B-Cell Lymphoma

NCT03656835

Conditions: Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Diffuse Large B-cell Lymphoma, +12 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

Cevostamab Following CAR T Cell Therapy for RRMM

NCT05801939

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

A Study of Polatuzumab Vedotin, Rituximab and Dose Attenuated CHP in Older Patients With DLBCL

NCT04594798

Conditions: DLBCL, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: University of Rochester Rochester, New York, United States

View Trial Details

Active, Not Recruiting

Mosunetuzumab and Polatuzumab Vedotin for Untreated Follicular Lymphoma

NCT05410418

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Active, Not Recruiting

A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia

NCT03330691

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

Riley Hospital for Children Indianapolis, Indiana, United States

Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma

NCT04270409

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: UCLA Site Number : 8400010 Los Angeles, California, United States

Colorado Blood Cancer Institute Site Number : 8400007 Denver, Colorado, United States

Cancer Specialist of North Florida Site Number : 8400011 Jacksonville, Florida, United States

University of Miami Site Number : 8400012 Miami, Florida, United States

View all 105 locations

View Trial Details

Active, Not Recruiting

CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant

NCT03560752

Conditions: Accelerated Phase CML, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, +41 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant

NCT04167683

Conditions: Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +28 more
Locations: Rigshospitalet Copenhagen, Denmark

View Trial Details

Active, Not Recruiting

Cellular Immunotherapy in Treating Patients With High-Risk Acute Lymphoblastic Leukemia

NCT02146924

Conditions: B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +21 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma

NCT03346135

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: City of Hope Medical Center Duarte, California, United States

Sarah Cannon Cancer Center Nashville, Tennessee, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions